Skip to main content

US ClosedU.S. Closed

Healthcare · Biotechnology

Benitec Biopharma Inc. , a clinical-stage biotechnology company, focuses on the development of novel genetic medicines.

52W Range

38thpctl

Volume

0.82×avg

Market Cap

428.40MUSD

P/E Ratio

-11.2TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Benitec Biopharma Inc.

BNTCNASDAQ Capital Market·USD·Closed

Benitec Biopharma Inc.

BNTCNASDAQ·USD·Closed

$12.47

−1.58%

$12.47

−$0.20 (1.58%)

52W Range

38thpctl

Volume

0.82×avg

Mkt Cap

428.40MUSD

P/E

-11.2TTM

Div Yield

–ann

BNTC: Benitec Biopharma Inc. Stock Analysis | finqOS